Curing Timothy Brown (02:02)

FREE PREVIEW

Brown is mentally and physically disabled. He discusses his HIV diagnosis in 1995 and leukemia diagnosis in 2006. Doctors at the Charité Clinic look for a stem cell donor. (Credits)

Genetic Defect Creates HIV Immunity (02:17)

Dr. Gero Hütter tries a new approach in HIV therapy. Learn how HIV enters a cell. Prof. Dr. Eckhard Thiel recalls Hütter's request to treat Timothy Brown.

Fighting HIV and Leukemia (02:33)

The Charité Clinic identifies a CCR5 donor for Timothy Brown. Despite his fear, Brown decided to undergo stem cell transplantation.

Doctors at the Charité Clinic Make Medical History (01:54)

Timothy Brown is cured of HIV and leukemia. Prof. Dr. Eckhard Thiel reflects on medical advancements during his career. Dr. Gero Hütter and Brown share their story with the public.

Providing Hope (04:09)

Since his treatment, Timothy Brown has been traveling the world to share his story. Experts reflect on Brown's message.

Retrovirus (01:38)

Experts discuss the improving prognosis of patients with HIV and explain how the virus reproduces.

HIV Positive Since 1992 (02:33)

HAART restrains the reproduction of HIV. Dirk Stöllger discusses his medication routine and not being contagious. Dr. Heiko Jessen discusses the declining fear of HIV.

Inactive Viruses (02:16)

HAART prevents AIDS from breaking out and lowers HI viruses to below the detection limit. Dr. Heiko Jessen discusses the role of reservoirs in therapy and considers long-term HAART effects.

Global Virus (02:38)

Experts discuss the expense of HAART, its accessibility, and HIV medication alternatives. They reflect on a cure for HIV/AIDS.

Cure for HIV in CCR5? (02:50)

Molecular Biologist Paula Cannon discusses funding for HIV/AIDS research. Her approach to a cure lies in Zinc Finger Nucleases.

Humanized Mice (01:36)

Molecular Biologist Paula Cannon and her team perform preclinical trials with genetic scissors on mice. She discusses building a resistance to HIV.

Gene Manipulation (04:29)

Matt Sharp has been HIV positive since 1988; he was one of the first to volunteer for clinical trials. Experts discuss the use of genetic scissors and their affect.

Treating Stem Cells with Genetic Scissors (01:59)

Molecular Biologist Paula Cannon discusses the possibility of cancer development. Her mouse trials were successful. Dr. Jacob Lalezari believes a slow careful approach is necessary.

Next Phase of Clinical Trials in San Francisco (02:59)

Christine Nellman has been HIV positive since 1987. Doctors are treating her blood cells with genetic scissors. Researchers discuss their test mice.

HIV Gene Therapy in Germany (01:53)

Researchers use naturally occurring enzymes to remove the HIV virus from an infected host cell; they are similar to genetic scissors.

HIV Virus Scissors (01:37)

Prof. Dr. Joachim Hauber discusses the continued trials on humanized mice and their current results; the next step is human trials.

HIV Immunity (03:47)

Immunologist Dennis Burton works to locate HIV antibodies to develop a HIV vaccine. The gap on the HIV spike always remains the same; antibodies target the gap.

HIV Vaccinations (02:16)

Immunologist Dennis Burton and his team work to develop a vaccine that activates the immune system to produce HIV antibodies. He discusses the challenges and hope for a positive outcome.

Scientific and Human Challenge (03:25)

Experts reflect on the various approaches to eliminating HIV, the effect of HIV stigma, and applying the approaches to other diseases.

Credits: The Berlin Patient (00:32)

Credits: The Berlin Patient